Fabrazyme (agalsidase beta) is an enzyme replacement therapy (ERT) that's FDA-approved for the treatment of a rare, inherited condition called Fabry disease in adults and children. It's administered as an intravenous (IV) infusion by a healthcare provider every 2 weeks. The dosing is calculated by your weight. Side effects include a higher risk of infections, chills, fever, and headache.
Fabrazyme (agalsidase beta) is an enzyme replacement therapy for people with Fabry disease. It replaces the missing alpha-galactosidase A (alpha-Gal A) enzyme in the body. This enzyme helps clear the buildup of fats called globotriaosylceramide (GL-3) that causes damage to the body in Fabry disease.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
More common
Blurred vision
chest pain, discomfort, or tightness
confusion
cough producing mucus
difficulty breathing
difficulty in moving
dizziness
faintness or lightheadedness when getting up suddenly from a lying or sitting position
feeling unusually cold shivering
headache
hives or welts, itching, skin rash
irregular heartbeat
joint pain
muscle ache, cramps, pains, or stiffness
nervousness
pounding in the ears
redness of the skin
stomach pain
sweating
swelling of the ankles, feet, and lower legs
swollen joints
unusual tiredness or weakness
Incidence unknown
Blue lips, fingernails, or skin
chills
cloudy or bloody urine
decreased cardiac output
decreased frequency or amount of urine
difficulty in speaking
difficulty swallowing
dilated neck veins
double vision
feeling of constant movement of self or surroundings
inability to move the arms, legs, or facial muscles
increased thirst
irregular, fast, or slow, or shallow breathing
lack or loss of strength
loss of appetite
lower back or side pain
no breathing
no pulse or blood pressure
noisy breathing
pain in the joints
pain or discomfort in the arms, jaw, back, or neck
problems with muscle control or coordination
seizures
sensation of spinning
severe or sudden headache
shakiness and unsteady walk
slow or slurred speech
swollen, painful, or tender lymph glands in the neck, armpit, or groin
temporary blindness
throat tightness
trembling
trouble breathing
unconsciousness
vomiting
weakness in the arm and/or leg on one side of the body, sudden and severe
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More Common
Acid or sour stomach
belching
body aches or pain
body produces substance that can bind to drug making it less effective or cause side effects
burning, crawling, itching, numbness, prickling, "pins and needles" , or tingling feelings
congestion
discouragement
dryness or soreness of the throat
fear
feeling sad or empty
fever, not related to infusion
hoarseness
indigestion
irritability
loss of interest or pleasure
pain or tenderness around eyes and cheekbones
paleness of skin
sensation of change in temperature
skeletal pain
trouble concentrating
trouble sleeping
voice changes
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Fabrazyme (agalsidase beta) was granted an accelerated approval by the FDA in 2003. After more clinical studies were conducted to confirm that the medication's clinical benefits for people with Fabry disease outweigh its risks, the FDA gave Fabrazyme (agalsidase beta) a full approval in 2021.
Fabrazyme (agalsidase beta) is given as a slow infusion through the veins. The infusion is typically administered by a healthcare provider at a medical office, infusion center, or hospital. Fabrazyme (agalsidase beta) isn't a medication you can pick up at the pharmacy and give to yourself at home. But after several infusions, your provider might let you get treatment at home. Talk to your provider to see whether it's an option to arrange for a nurse to administer your infusion at home.
How long your Fabrazyme (agalsidase beta) infusion takes depends on your weight and how well you're tolerating the infusion. The infusion should take at least an hour and a half. It might take a little longer for the infusion to finish if you're experiencing infusion-related reactions. This is because your provider will slow down or temporarily stop the infusion to manage your symptoms. Plan ahead of time and bring something to do to help pass the time, such as a book or an electronic device.
Fabrazyme (agalsidase beta) is an enzyme replacement therapy. It's a lab-made version of the alpha-Gal A enzyme that your body normally makes. The medication replaces the missing alpha-Gal A enzyme in people with Fabry disease.
Animal and human studies haven't suggested that Fabrazyme (agalsidase beta) raises the risk of harm to unborn babies when it's taken during pregnancy. But some animal studies showed evidence of liver damage in mothers after taking the medication at doses much higher than those used in humans. If you're prescribed Fabrazyme (agalsidase beta) during pregnancy, you're encouraged to enroll in the Fabry registry. This registry keeps track of your health and your baby's health. To enroll, visit the registry's website or call 1-800-745-4447, extension 15500. Also, make sure to have a discussion with your provider if you're pregnant or planning to get pregnant during your Fabrazyme (agalsidase beta) treatment.
Fabry disease is a rare, inherited condition. The body can't make enough of a protein called alpha-galactosidase A (alpha-Gal A) to help get rid of certain fats (GL-3) from your body. As a result, the fats start to collect in blood vessels, the kidneys, the heart, and many other organs. Extra fats can cause nerve pain; small, red spots on the skin; hearing loss; and digestive problems. Over time, the buildup of fats can also cause serious problems, such as kidney damage, heart problems like heart attack, and stroke. Everyone can have different signs and symptoms of this condition. It's important to follow up with a provider often if you have Fabry disease, even if you don't have any signs and symptoms. Your providers can discuss with you about treatment options like Fabrazyme (agalsidase beta).
Fabrazyme (agalsidase beta) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Serious allergic reactions to Fabrazyme (agalsidase beta) are possible. These reactions can include life-threatening problems like anaphylaxis (closing of the throat and trouble breathing) and angioedema (swelling of the lips, tongue, face, or throat). The risk for severe allergic reactions might be higher in people with anti-Fabrazyme antibodies — antibodies your immune system made against the medication as an allergic response — in the blood. Tell your provider right away if you begin to have any trouble breathing, trouble swallowing, severe swelling, or hives.
In clinical studies, over half of people who took Fabrazyme (agalsidase beta) experienced reactions during their infusions. These reactions can include fever, chills, dizziness, nausea, stomach pain, muscle pain, changes in heartbeat, or a feeling of "pins and needles," among others.
Tell your provider if you feel unwell at any point during your Fabrazyme (agalsidase beta) infusion. Your provider can adjust the infusion rate, temporarily stop the infusion, or give you medications to manage your symptoms. Call a provider if you have any reactions after your infusion as well.
If you've had an infusion reaction, your provider might give you medications to prevent reactions before your infusion at your next treatment session. Your provider might also observe you after your infusion to see how you respond to the medication in case you need appropriate treatment.
The dose is based on your body weight. The typical dose is 1 mg/kg of weight every 2 weeks as an infusion into your veins (intravenous or IV infusion).
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.